drugset / Trial / NCT03514277

A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief

NCT03514277 ↗

Phase 4 Terminated 19 enrolled Virtua Health, Inc.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to collect information about how patients feel when doctors manage their pain after lumbar spine surgery using a combination of EXPAREL® and bupivacaine injected into the lumbar spine at the end of surgery, compared to the patients that doctors use only EXPAREL® or bupivacaine to manage their pain. This information will help doctors determine which approach works best for patients who will receive surgery in their lumbar spine in the future.

Timeline

Start
2016-12-01
Primary completion
2019-12-31
Completion
2019-12-31

Outcome

Outcome not reported

Stopped: “PI decision to close study early”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other